Stellate cells in livers of dogs with portal vein hypoperfusion

• Autorzy: Sobczak-Filipiak M. , Szarek J. , Czopowicz M. , Galanty M. , Dolka I. , Trebacz P. , Frymus J. , Lechowski R.
• Języki publikacji: EN

Abstrakty

EN

Hepatic stellate cells play a crucial role in the development of liver fibrosis. In a damaged liver, stellate cells undergo activation, which is manifested as a change of their phenotype: differentiation of stellate cells to myofibroblast-type cells, expression of alpha-Smooth Muscle Actin, their proliferation and a reduction in the size of cytoplasmic lipid droplets. The aim of this study was to determine the number and morphology of stellate cells in the canine liver affected by congenital portosystemic shunt (PSS) and portal vein hypoplasia – hepatic microvascular dysplasia (PVH-HMD). The material for investigation were archived paraffin blocks with liver samples collected supravitally from six dogs with PSS, six dogs with PVH-HMD and six healthy dogs. On the HE-stained sections, the number of stellate cells per 100 hepatocytes was counted (Sztark method) and the diameter of veins in the hepatic triads was measured (light microscope Olympus BX 43, SC30 camera, CellSens Entry 2011 Olympus). In addition, the diameter of lipid droplets in stellate cells was measured (computed image analysis system LUCIA 4.21). The results were analysed statistically (the Kruskal-Wallis test followed by Dunn’s post-hoc procedure; significance level (α) at 0.05; Statistica 12 StatSoft Inc.). The degree of liver fibrosis was determined (Masson’s method of slide stain; Scheuer scale). The liver samples from the dogs with PSS and PVH-HMD were stained immunohistochemically with Monoclonal Mouse Anti-Human Smooth Muscle Actin (α-SMA), clone 1A4, antibodies (DAKO). Portosystemic shunt and primary portal vein hypoplasia in the dog results in a reduction in the diameter of portal vein branches and in insufficient portal blood flow through the liver. In the material investigated, this was particularly evident in the animals affected by PSS: such dogs had a significantly smaller diameter of the veins than did the healthy dogs (p < 0.001) or the dogs with PVH-HMD (p = 0.023). Fibrosis and the expression of α-SMA were stronger in the dogs with PSS than in those with PVH-HMD. Moreover, the dogs with PSS had a significantly higher average number of stellate cells than the healthy animals (p = 0.007) did. However, the examination of the material revealed an enlargement of cytoplasmic lipid droplets: the dogs with PSS had a significantly larger diameter of lipid vacuoles in the cytoplasm of stellate cells than did the healthy animals (p < 0.001) or the dogs with PVH-HMD (p = 0.043); the dogs with PVH-HMD had lipid droplets with a significantly larger diameter than the healthy animals (p < 0.001) did. Hypoperfusion of the liver and the accompanying regressive lesions in hepatocytes result mainly in an increased number of stellate cells and stronger expression of α-SMA, while cytoplasmic lipid droplets in the stellate cells are not reduced in size. The present study indicates the need for detailed analyses of clinical cases and warrants further comprehensive studies of comparative hepatopathology because it demonstrates differences between humans and dogs in the morphological indicators of hepatic stellate cell activation in chronic liver damage.

Słowa kluczowe

EN

animal disease; dog; hepatic stellate cell; stellate cell; liver; portal vein hypoperfusion; portal vein hypoplasia

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2018
• Tom: 74
• Numer: 06
• Opis fizyczny: p.392-397,fig.,ref.

Twórcy

autor

Sobczak-Filipiak M.

• Department of Pathology and Veterinary Diagnostics, Warsaw University of Life Sciences - SGGW, Nowoursynowska St. 159C, 02-776 Warsaw, Poland

autor

Szarek J.

• Department of Pathophysiology, Forensic Veterinary Medicine and Administration, University of Warmia and Mazury in Olsztyn, Oczapowskiego St. 13, 10-719 Olsztyn, Poland

autor

Czopowicz M.

• Laboratory of Veterinary Epidemiology and Economics, Warsaw University of Life Sciences - SGGW, Nowoursynowska St. 159C, 02-776 Warsaw, Poland

autor

Galanty M.

• Department of Small Animal Diseases with Clinic, Faculty of Veterinary Medicine, Warsaw University of Life Sciences - SGGW, Nowoursynowska St. 159C, 02-776 Warsaw, Poland

autor

Dolka I.

• Department of Pathology and Veterinary Diagnostics, Warsaw University of Life Sciences - SGGW, Nowoursynowska St. 159C, 02-776 Warsaw, Poland

autor

Trebacz P.

• Department of Small Animal Diseases with Clinic, Faculty of Veterinary Medicine, Warsaw University of Life Sciences - SGGW, Nowoursynowska St. 159C, 02-776 Warsaw, Poland

autor

Frymus J.

• Department of Small Animal Diseases with Clinic, Faculty of Veterinary Medicine, Warsaw University of Life Sciences - SGGW, Nowoursynowska St. 159C, 02-776 Warsaw, Poland

autor

Lechowski R.

• Department of Small Animal Diseases with Clinic, Faculty of Veterinary Medicine, Warsaw University of Life Sciences - SGGW, Nowoursynowska St. 159C, 02-776 Warsaw, Poland

Bibliografia

• Aleksic-Kovacevic S., Kukolj V., Kureljusic B., Marinkovic D., Knezevic D., Ignjatovic I., Jovanovic M., Knezevic M., Gledic D.: Role of hepatic stellate cells (HSCs) in the development of hepatic fibrosis in cats with polycystic kidney disease (PKD). Acta Vet. Beograd 2010, 60, 391-400.
• Atzori L., Poli G., Perra A.: Hepatic stellate cells: a star cell in the liver. Int. J. Biochem. Cell Biol. 2009, 41, 1639-1642.
• Baade S., Auperle H., Grevel V., Schoon H. A.: Histopatological and immunohistochemical investigations of hepatic lesions associated with congenital portosystemic shunts in dogs. J. Comp. Pathol. 2006, 134, 80-90.
• Bancroft J. D., Cook H. C.: Manual of Histological Techniques and their Diagnostic Application. Churchill Livingstone, Edinburgh, London, Madrid, Melbourne, New York, Tokyo 2000.
• Budny T., Palmers D., Stratman U., Minin E., Herbst H., Spiegel H. U.: Morphologic features in the regenerating liver – a comparative intravital, light microscopical and ultrastructural analysis with focus on hepatic stellate cells. Virchows Arch. 2007, 451, 781-791.
• Carpino G., Franchito A., Morini S., Corradini S. G., Merli M., Gaudio E.: Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study. Ital. J. Anat. Embryol. 2004, 109, 225-238.
• Chong-Yang Z., Wei-Gang Y., Pei H., Jia-Hui L., Chun-Xu W.: Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets. World J. Gastroenterol. 2016, 22, 10512-10522.
• Christiansen J. S., Hottinger H. A., Allen L., Philips L., Aronson L. R.: Hepatic microvascular dysplasia in dogs: a retrospective study of 24 cases (1987-1995). J. Am. Anim. Hosp. Assoc. 2000, 36, 385-389.
• Cullen J. M., Ingh T. S. G. A. M. van den, Bunch S. E., Rothuizen J., Washabau R. J., Desmet V. J.: Morphological classification of circulatory disorders of the canine and feline liver, [in:] WSAVA Liver Standardization Group: WSAVA Standards for clinical and histological diagnosis of canine and feline liver diseases. Saunders Elsevier, Spain 2006, 41-59.
• Cullen M. J., Stalker M. J.: Hepatocellular adaptations and intracellular accumulation, [in:] Maxie G. M. (ed.): Jubb, Kennedy and Palmer’s pathology of domestic animals, 6th edition. ELSEVIER Incorporation, St. Louis, Missouri 2016, p. 269-278.
• Flisiak R.: Role of Ito cells in the liver function. Pol. J. Pathol. 1997, 48, 139-145.
• Friedman S. L.: Molecular regulation of hepatic fibrosis; an integrated cellular response to tissue injury. J. Biol. Chem. 2000, 275, 2247-2250.
• Gabriel A., Mietkiewski J., Ziółkowski A.: Aktualna klasyfikacja morfologiczna przewlekłych zapaleń wątroby: zalety i wady. Pol. J. Pathol. 1999, 50, 5-11.
• Gough A., Thomas A.: Breed Predispositions to Disease in Dogs and Cats. SIMA WLW, Warszawa 2006.
• Guerra J. M., Daniel A. G., Aloia T. P., de Sigueira A., Fukushima A. R., Simoes D. M., Reche-Juior A., Cogliati B.: Hypervitaminosis A-induced hepatic fibrosis in cats. J. Feline Med. Surg. 2014, 16, 243-248.
• Hellerbrand C.: Hepatic stellate cells – the pericytes of the liver. Pfluges Arch. 2013, 465, 775-778.
• Ijzer J., Roskams T., Molenbeek R. F., Ultee T., Penning L. C., Rothuizen J., van den Ingh T. S.: Morphological characterization of portal myofibroblasts and hepatic stellate cells in the normal dog liver. Comp. Hepatol. 2006, 16, 7.
• Johnson S. E.: Chronic hepatic disorders, [in:] Ettinger S. J., Feldman E. C. (ed.): Textbook of Veterinary Internal Medicine. vol. 2, 5th ed., Section XI, Chapter 143, W. B. Saunders Company, Philadelphia 2000, p. 1298-1325.
• Kmieć Z.: The role of hepatic stellate cells in the regulation of the liver functions. II. Cooperation with other cell types in the development of liver fibrosis. Adv. Cell Biol. 2002, 30, 61-74.
• Knittel T., Kobold D., Saile B., Grundmann A., Neubauer K., Piscaglia F., Ramadori G.: Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 1999, 117, 1205-1221.
• Kobayashi K., Sakata K., Miyata K., Iino T., Iwasaki S., Takahashi K.: Mast cell-Ito cell pairings found in the Disse’s spaces in the liver of the Beagle dog. Arch. Histol. Jpn. 1985, 48, 483-496.
• Levine P. H. L., Delgado Y., Theise N. D., West A. B.: Stellate-cell lipidosis in liver biopsy specimens. Recognition and significance. Am. J. Clin. Pathol. 2003, 119, 254-258.
• Li D., Friedman S. L.: Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J. Gastroenterol. 1999, 14, 618-633.
• Li D., Kim J. H.: The role of activated hepatic stellate cells in liver fibrosis, portal hypertension and cancer angiogenesis. Korean J. Hepatol. 2007, 13, 309-319.
• Nelson R. W., Couto C. G.: Choroby wątroby i dróg żółciowych psów, [in:] Lechowski R., Schollenberger A., Pomianowski A. (ed.): Choroby wewnętrzne małych zwierząt. Polish edition, Publishing House Galaktyka, Łódź 2008, p. 373-387.
• Plewka K., Szuster-Ciesielska A., Kandefer-Szerszeń M.: Role of stellate cells in alcoholic liver fibrosis. Postępy Hig. Med. Dośw. 2009, 63, 303-317.
• Richter K. P.: Diseases of the liver and hepatobilliary system, [in:] Tams T. R. (ed.): Handbook of Small Animal Gastroenterology, 2nd edition, Chapter 9. Saunders, USA 2003, p. 286-352.
• Schotanus B. A., van den Ingh T. S., Penning L. C., Rothuizen J., Roskams T. A., Spee B.: Cross-species immunohistochemical investigation of the activation of the liver progenitor cell niche in different types of liver disease. Liver Int. 2009, 29, 1241-1252.
• Sobczak-Filipiak M., Szarek J., Czopowicz M., Mieczkowska J., Lechowski R.: Hepatic stellate cells in the liver in dogs with steroid-induced hepatopathy. Bull. Vet. Inst. Puławy 2014, 58, 272-276.
• Stalker M. J., Hayes M. A.: Liver and biliary system, [in:] Maxie M. G. (ed.): Jubb, Kennedy and Palmer’s Pathology of Domestic Animals. 5th edition, vol. 2. Saunders Ltd., China 2007, p. 297-388.
• Takuma T., Friedmann S. L.: Mechanisms of hepatic stellate cell activation. Nat. Rev. Gastro. Hepat. 2017, 14, 397-411.
• Yin C., Evason K. J., Asahina K., Stainier D. Y. R.: Hepatic stellate cells in liver development, regeneration, and cancer. J. Clin. Invest. 2013, 123, 1902-1910.

Identyfikatory

DOI

10.21521/mw.6017